Virax Biolabs Group Ltd (VRAX) Operating Leases (2024 - 2025)
Virax Biolabs (VRAX) posted Operating Leases of $344536.0 for Q1 2025, up 95.38% on a QoQ basis from $176345.0 in Q1 2024, and up 95.38% year-over-year from $176345.0 in Q1 2024.
Virax Biolabs (VRAX) has 2 years of Operating Leases data on file, last reported at $344536.0 in Q1 2025.
- In Q1 2025, Operating Leases rose 95.38% year-over-year to $344536.0; the TTM figure through Mar 2025 stood at $344536.0 (up 95.38% YoY), while the FY2025 annual figure was $344536.0, up 95.38% from the prior year.
- Operating Leases rose to $344536.0 in Q1 2025, from $176345.0 in the prior quarter.
- Across five years, Operating Leases topped out at $344536.0 in Q1 2025 and bottomed at $176345.0 in Q1 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 344,536.00 |
| Mar 31, 2024 | 176,345.00 |